Clear Gene provides RNA diagnostic tools, including a rapid COVID-19 test, for clinical labs. Their cloud-based software helps labs analyze results from existing PCR instruments, enabling faster and more efficient testing workflows. The company focuses on combining data science and molecular assays to improve diagnostic testing.
Funding
Funding not disclosed
Founders
Product
Problem
Clinical labs often face challenges in processing a high volume of samples efficiently and cost-effectively, especially when using multiple PCR instruments and tests. Analyzing results from these various sources can be complex and time-consuming, requiring multiple interpretive software programs. Detecting residual solid tumors, particularly in comparison to liquid tumors, presents a significant diagnostic challenge.
Solution
Clear Gene provides RNA diagnostic tools and cloud-based software solutions designed to streamline and enhance the efficiency of clinical labs. Their MICA Software™ employs an advanced signal-processing algorithm to improve the reliability of Ct calls, consolidating multiple interpretive software programs into a single interface. Clear Gene also offers MICA Test Kits as rapid and sensitive replacements for traditional PCR methods. Additionally, MICA–Direct™ Kits provide reagents for 5-minute RNA extractions, replacing tedious RNA isolation processes and ensuring compatibility with PCR and isothermal tests. Clear Gene leverages genomics and machine learning to improve the detection of residual solid tumors, addressing a critical unmet need in cancer diagnostics.
Target Audience
Clear Gene's primary customers are clinical labs seeking to improve the efficiency, accuracy, and cost-effectiveness of their RNA diagnostic testing, including COVID-19 testing and residual disease detection.
Features
- MICA Software™: Cloud-based platform for reliable Ct call analysis using advanced signal processing.
- Compatibility with existing PCR instruments, eliminating the need for new hardware investments.
- MICA Test Kits: Rapid and sensitive drop-in replacements for traditional PCR tests.
- MICA–Direct™ Kits: Reagents for rapid 5-minute RNA extraction compatible with PCR and isothermal tests.
- Application of genomics and machine learning for improved detection of residual solid tumors.
- Streamlined workflow for processing more samples at a lower cost.